Dr. Neil Riordan on health: what the evidence says · JRE #1066

FACT CHECK // JRE #1066 // EXHIBIT LOG
EPISODE AIRED JAN 1, 2018 · THE JOE ROGAN EXPERIENCE
CLAIM CMRC8IBWSTATUS: PUBLISHED
SUBJECT: HEALTH
Timestamp53:27
Aired
// 00 · ABSTRACT

The short answer

Riordan claims his own cohort analysis found 100% of spinal cord injury patients treated within one year of injury regained some neurologic function, versus 82% between one and two years. No peer-reviewed publication reporting these specific figures could be located; the claim appears to originate from unpublished clinic data rather than an independently reviewed study.

RulingNeeds Context

Not a true/false call. Every claim is logged with its sources; read the exhibits below.

// THE CLAIM · ON TAPE
like for spinal cord injury, we did a cohort analysis, and basically if they're within one year of injury, 100% of the patients had restoration of some neurologic function. If it was between one and two years, it was 82%.
Dr. Neil Riordan@ 53:27
Watch on YouTubeJUMP TO 53:27

What the evidence says 01 / RECORD

Riordan, founder of the for-profit Stem Cell Institute in Panama, cited an internal "cohort analysis" claiming 100% of spinal cord injury patients treated within one year of injury regained some neurologic function, versus 82% treated one to two years post-injury. No peer-reviewed publication reporting these specific figures could be located; the claim appears to originate from unpublished clinic data rather than an independently reviewed study. The largest independent meta-analysis of stem cell therapy for spinal cord injury (62 trials, 2,439 patients) found that stem cells improved ASIA impairment scale grade by at least one level in only about 49% of patients, well below the 82-100% Riordan reports, and concluded current evidence is not strong enough to support clinical translation of stem cell therapy for spinal cord injury. Independent natural-history data also show that a meaningful fraction of incomplete spinal cord injuries recover some neurologic function spontaneously in the first year without any stem cell intervention, which complicates attributing improvement solely to treatment in an uncontrolled cohort. Because Riordan's figures come from his own clinic, are not published in a form that can be independently verified, and lack a control group, the claim is unsupported by the current independent evidence base.

[ FOLLOW THE MONEY ]

Who Benefits

Riordan is the founder of the Stem Cell Institute in Panama, the for-profit clinic that administers the stem cell treatment for spinal cord injury described in the cohort data he cites, giving him a direct financial interest in favorable outcome reporting.

/// factcheckjoerogan.com